FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/08/2026
Voltar para busca
Dado oficial do USPTO
BIOMEBANK
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BIOMEBANK
ST13
US500000079378921Classe
5, 42, 44
Pedido
79378921
Registro
8097613
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
05/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
23/08/2023
Data de registro
13/01/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/01/2026
Última transação
05/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
AU
Examinador
BURRUS, JESSICA E
Localização atual
Historical data usage
Titulares e representantes
Titulares
COST-BRY PTY LTD
Representantes
Jocelyn C. Smith UB Greensfelder LLP
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Biological agentsbacterial fungicidesfungicidesweedkillersherbicidesinsecticidesparasiticidespesticides; biological control agents being pesticides; biological preparations for medical purposesthe treatment of cancer; biological preparations for pharmaceutical purposesthe treatment of cancer; biological preparations for use in cell cultures in biotechnology for medical purposes; biological preparations for use in cell cultures for medical purposes; biological products being reagents for medical use; biological substances being reagents for medical use; biological tissue cultures for medical purposes; biological reagants for use in biological processing for medical purposes; bacteriological culture mediums for medical purposes or veterinary purposes; bacteriological cultures for medical and veterinary use; bacteriological preparations for medical and veterinary use; diagnostic test reagants for medical use in detecting allergenic substances
Classe 42
Biological research in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; bacteriological research in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; biotechnology research in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; biotechnology testing of materials in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; advisory services relating to scientific research in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; technology advisory services related to biotechnological engineering research in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; biochemistry research services in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; scientific research in the field of biotechnology animal genetics research in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; medical research services in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; scientific research for medical purposes in the field of cancerous diseases for the developmenttestingtreatment of cultured microbial therapies; scientific researchpreparation of reports in the field of in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; Technical researchin the field of in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; scientific researchconducting statistical scientific studies in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; providing information in the field of scientific and technological research and design services via a web site in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; provision of information relating to scientific research in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; provision of medical research services in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; rental of scientific research facilities in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; research and development of new products in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; scientific research in the field of bacteriology for the developmenttestingtreatment of cultured microbial therapies; scientific research and development of new products in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; scientific research in the field of biology for the developmenttestingtreatment of cultured microbial therapies; scientific research in the field of genetics for the developmenttestingtreatment of cultured microbial therapies; technological research in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; providing scientific information in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; scientific research in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies.
Classe 44
Medical advisory servicesadvisory services relating to medical services for the testing and treatment of cultured microbial therapies; alternative medical services for the testing and treatment of cultured microbial therapies; charitable servicesproviding medical services to underserved communities for the testing and treatment of cultured microbial therapies; medical services in the field of gastroenterology for the testing and treatment of cultured microbial therapies; medical diagnostic services in the nature of testing and analysis services for the testing and treatment of cultured microbial therapies; medical advisory servicesadvisory services relating to medical problems for the testing and treatment of cultured microbial therapies.
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
FIMP
FINAL DISPOSITION PROCESSED
05/08/2026
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
05/08/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/06/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13/04/2026
ES7R
TEAS SECTION 7 REQUEST RECEIVED
02/03/2026
CHPN
POST PUBLICATION AMENDMENT – NOT ENTERED
14/01/2026
APET
ASSIGNED TO PETITION STAFF
13/01/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
13/01/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
13/01/2026
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
18/12/2025
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
10/11/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
28/08/2025
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
07/07/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/06/2025
PUBO
PUBLISHED FOR OPPOSITION
10/06/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/06/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/05/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/02/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/01/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/01/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/01/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
30/08/2024
RFNT
REFUSAL PROCESSED BY IB
28/07/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/07/2024
RFRR
REFUSAL PROCESSED BY MPU
06/07/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/06/2024
CNRT
NON-FINAL ACTION WRITTEN
17/05/2024
DOCK
ASSIGNED TO EXAMINER
24/04/2024
MAFR
APPLICATION FILING RECEIPT MAILED
19/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/09/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
14/09/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIOMEBANK ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.